(C) 2012 Elsevier Inc. All rights reserved.”
“The quite efficient adsorption of methylene blue dye from an aqueous solution by graphene oxide was studied. The favorable electrostatic attraction is the main STI571 in vitro interaction between methylene blue and graphene oxide. As graphene oxide has the special nanostructural properties and negatively charged surface, the positively charged methylene

blue molecules can be easily adsorbed on it. In the aqueous solution of methylene blue at 293 K, the adsorption data could be fitted by the Langmuir equation with a maximum adsorption amount of 1.939 mg/mg and a Langmuir adsorption equilibrium constant of 18.486 mL/mg. The adsorption amount increased with the increase of the solution pH (3-11), was not affected significantly NVP-BSK805 molecular weight by KCl under the examined condition and the adsorption process was exothermic in nature. The fast and considerable adsorption of graphene oxide could be regarded as a potential adsorbent for cationic dye removal in wastewater treatment process.”
“BACKGROUND

& AIMS: Activation of protein kinase C (PKC) enzymes in liver and brain alters hepatic glucose metabolism, but little is known about their role in glucose regulation in the gastrointestinal tract. We investigated whether activation of PKC-delta in the duodenum is sufficient and necessary for duodenal nutrient sensing and regulates hepatic glucose production through a neuronal network in rats. METHODS: In rats, we inhibited duodenal PKC and evaluated whether nutrient-sensing mechanisms, activated by refeeding, have disruptions in glucose regulation. We then performed gain-and loss-of-function pharmacologic and molecular experiments to target duodenal PKC-delta; we evaluated the impact on glucose production regulation during the pancreatic clamping, while basal levels of insulin were maintained. RESULTS: PKC-delta was detected in the

mucosal layer of the duodenum; intraduodenal infusion of PKC inhibitors disrupted glucose homeostasis during refeeding, indicating that duodenal activation of PKC-delta is necessary and sufficient to regulate glucose homeostasis. Intraduodenal infusion of the PKC activator 1-oleoyl-2-acetyl-sn-glycerol (OAG) specifically activated duodenal mucosal PKC-delta and a gutbrain-liver neuronal pathway to GSI-IX reduce glucose production. Molecular and pharmacologic inhibition of duodenal mucosal PKC-delta negated the ability of duodenal OAG and lipids to reduce glucose production. CONCLUSIONS: In the duodenal mucosa, PKC-delta regulates glucose homeostasis.”
“In addition to its role in the pathophysiology of numerous psychiatric disorders, increasing evidence points to serotonin (5-HT) as a crucial molecule for the modulation of neurodevelopmental processes. Recent evidence indicates that the placenta is involved in the synthesis of 5-HT from maternally derived tryptophan (TRP).